Necrolytic Migratory Erythema
- PMID: 30422467
- Bookshelf ID: NBK532872
Necrolytic Migratory Erythema
Excerpt
Necrolytic migratory erythema (NME) is a characteristic skin rash most often associated with glucagonoma, an alpha-cell tumor of the pancreatic islets. It is usually seen as a part of the glucagonoma syndrome, a paraneoplastic syndrome that includes the triad of diabetes mellitus, NME, and weight loss. However, more rarely, NME can also be seen as a part of other clinical entities such as liver disease and intestinal malabsorption; here, it is termed the pseudoglucagonoma syndrome.
The skin rash is characteristically extremely erythematous, shows superficial epidermal necrosis, and often spreads in a centrifugal pattern. The condition is frequently misdiagnosed due in part to its rarity. It is the presenting symptom of the pancreatic islet neoplasm. Thus, timely recognition and treatment can help prevent morbidity from the epidermal dysfunction and mortality from the tumor burden itself if the neoplasm is identified before metastasis.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Tolliver S, Graham J, Kaffenberger BH. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema. Int J Dermatol. 2018 Jun;57(6):642-645. - PubMed
-
- Lobo I, Carvalho A, Amaral C, Machado S, Carvalho R. Glucagonoma syndrome and necrolytic migratory erythema. Int J Dermatol. 2010 Jan;49(1):24-9. - PubMed
-
- John AM, Schwartz RA. Glucagonoma syndrome: a review and update on treatment. J Eur Acad Dermatol Venereol. 2016 Dec;30(12):2016-2022. - PubMed
-
- van Beek AP, de Haas ER, van Vloten WA, Lips CJ, Roijers JF, Canninga-van Dijk MR. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review. Eur J Endocrinol. 2004 Nov;151(5):531-7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources